Scientific Sessions 2025  /  Lipid Therapies: Translation to Implementation  /  Moving the Needle on Lipid Management: Getting to Goal
Logo

American Heart Association

  46
  0

Final ID:

Moving the Needle on Lipid Management: Getting to Goal

  • Schwartz, Gregory  ( VA EASTERN COLORADO HEALTHCARE SYST , Aurora , Colorado , United States )
    • Author Disclosures:
    Gregory Schwartz: DO have relevant financial relationships ; Researcher:AstraZeneca:Active (exists now) ; Researcher:Silence Therapeutics:Active (exists now) ; Researcher:Sanofi:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Lipid Therapies: Translation to Implementation

Monday, 11/10/2025 , 03:15PM - 04:30PM

Featured Science

More abstracts on this topic:
Effects of Real-Time Notification of AI-Derived Incidental Coronary Artery Calcium on Statin Initiation: the NOTIFY-PICTURE Trial

Dudum Ramzi, Chaudhari Akshay, Sandhu Alexander, Maron David, Rodriguez Fatima, Jain Sneha, Mastrodicasa Domenico, Ngo Summer, Furst Adam, Xu Shiqin, Eng David, Khandwala Nishith, Langlotz Curtis

SHR-1918, an Angiopoietin-Like 3 Antibody, in Patients With Suboptimally Controlled Hyperlipidemia

Zhong Zhixiong, Zhu Min, Zhu Ying, Zhang Jing, Dan Zhu, Pei Hanjun, Wu Wanling, Huang Rongjie, Yin Delu, Gao Xiaohong, Lv Chao

More abstracts from these authors:
Discussant: META-AF

Potpara Tatjana, Chung Mina, Schwartz Gregory

The Effect of PCSK9 Inhibition With Alirocumab in Patients With Probable Familial Hypercholesterolemia or Type III Hyperlipoproteinemia: Results from the ODYSSEY OUTCOMES Trial

Geba Gregory, Bittner Vera, Bhatt Deepak, Szarek Michael, Schwartz Gregory, Steg Philippe, Fazio Sergio, Mohammadi Kusha, Damask Amy, Paulding Charles, Lotta Luca, Hindy George, Pordy Robert, Manvelian Garen, Shapiro Michael

You have to be authorized to contact abstract author. Please, Login
Not Available